Molecular determinants of human adipose tissue: Differences between visceral and subcutaneous compartments in obese women

被引:36
作者
Giusti, V [1 ]
Suter, M
Verdumo, C
Gaillard, RC
Burckhardt, P
Pralong, FP
机构
[1] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Dept Surg, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Div Endocrinol Diabetol & Metab, CH-1011 Lausanne, Switzerland
关键词
D O I
10.1210/jc.2003-031507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adipose tissue is playing an important role in the development of human obesity and its related comorbidities, but little is known about the mechanisms governing its differentiation and proliferation. In this work, we studied the expression of transcription factors involved in fat storage and metabolic regulations in adipose tissue of 50 well-characterized obese women. In multivariate analyses, 80% of c enhancer binding protein alpha (cEBPalpha), c and a sterol regulatory element binding protein 1 (c and a SREBP1), and retinoid X receptor (RXRalpha) levels in sc adipose tissue (SAT) could be explained by other transcription factors. In addition, RXRalpha was the major determinant of peroxisome proliferator and activated receptor-gamma1 variability in SAT, with the two factors being involved in the determination of the variability of insulin resistance. In contrast, the levels of all these transcription factors, together with various phenotypic and biological characteristics of the patients, seemed to participate only marginally in the regulation of visceral adipose tissue activity. In similar multivariate analyses, they could explain only a minor part of the variability of cEBPalpha, c and a SREBP1, or RXRalpha, suggesting the involvement of other regulators. Overall, our results demonstrate a different regulation of visceral adipose tissue and SAT and a different role of both tissues in insulin resistance and lipid storage.
引用
收藏
页码:1379 / 1384
页数:6
相关论文
共 56 条
[1]   HETEROGENEITY IN ADIPOSE-TISSUE METABOLISM - CAUSES, IMPLICATIONS AND MANAGEMENT OF REGIONAL ADIPOSITY [J].
ABATE, N ;
GARG, A .
PROGRESS IN LIPID RESEARCH, 1995, 34 (01) :53-70
[2]  
AILHAUD G, 1992, INT J OBESITY, V16, pS17
[3]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[4]   Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells [J].
Aubert, J ;
Darimont, C ;
Safonova, I ;
Ailhaud, G ;
Negrel, R .
BIOCHEMICAL JOURNAL, 1997, 328 :701-706
[5]   Transcription, adipocyte differentiation, and obesity [J].
Auwerx, J ;
Martin, G ;
GuerreMillo, M ;
Staels, B .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (07) :347-352
[6]  
Bjorntorp P, 1996, INT J OBESITY, V20, P291
[7]   SITE DIFFERENCES IN INSULIN-RECEPTOR BINDING AND INSULIN ACTION IN SUBCUTANEOUS FAT OF OBESE FEMALES [J].
BOLINDER, J ;
ENGFELDT, P ;
OSTMAN, J ;
ARNER, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) :455-461
[8]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[9]  
CHOY LN, 1992, J BIOL CHEM, V267, P12736
[10]   Molecular regulation of adipocyte differentiation [J].
Cowherd, RM ;
Lyle, RE ;
McGehee, RE .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (01) :3-10